搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
FierceBiotech
8 小时
FDA approves Humacyte’s off-the-shelf artery implant for vascular trauma repair
The FDA has granted a groundbreaking approval to Humacyte for its off-the-shelf, bioengineered blood vessel implant, designed ...
TCTMD
4 小时
Radial Artery Best for Secondary Access During TAVI: PULSE Registry
Complication rates, including bleeding, were significantly lower when the radial artery was used over a second femoral ...
SheFinds on MSN
6 天
3 Artery-Clogging Packaged Foods That Could Be Hurting Your Cardiovascular Health ...
The food you eat is of crucial importance to your overall wellbeing, especially when it comes to the health of your heart.
TheHealthSite
6 天
Clogged Arteries In Men 20s: Warning Signs In Legs And Feet You Shouldn't Ignore After 10pm
Are you suffering from clogged arteries or arterial blockage? Here are the top 7 signs in legs and feet that shouldn't be ...
newsbytesapp.com
4 天
Elevating circumflex artery health with five cardio exercises
Cardiovascular exercises are vital for a healthy heart and circulatory system. Focusing on the circumflex artery, which ...
Daily
1 天
FDA Approves First Acellular Tissue Engineered Vessel to Treat Vascular Trauma in Extremities
The U.S. Food and Drug Administration approved Symvess, the first acellular tissue engineered vessel indicated for use in ...
2 天
Introducing intravascular lithotripsy: Sonic waves strike UH Ashland's catheterization lab
The catheterization lab has an interventional tool that uses ultrasound shockwaves to strike coronary artery calcium.
9 小时
Humacyte price target raised to $17 from $15 at Benchmark
Benchmark analyst Bruce Jackson raised the firm’s price target on Humacyte (HUMA) to $17 from $15 and keeps a Buy rating on the shares.
Endovascular Today
3 天
Humacyte’s Symvess ATEV Approved by FDA for Treatment of Extremity Vascular Trauma
Humacyte, Inc. announced that the FDA has granted full approval for the company’s Symvess—acellular tissue enginee ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈